CareRx Corporation (CHHHF)
USD 1.28
(0.0%)
USD 1.28
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 57.14 Million CAD | -54.36% |
| 2022 | 125.21 Million CAD | 0.73% |
| 2021 | 124.3 Million CAD | 63.33% |
| 2020 | 76.1 Million CAD | 269.8% |
| 2019 | 20.58 Million CAD | 10454.36% |
| 2018 | 195 Thousand CAD | 43.38% |
| 2017 | 136 Thousand CAD | -99.78% |
| 2016 | 61.77 Million CAD | -71.29% |
| 2015 | 215.16 Million CAD | -10.46% |
| 2014 | 240.29 Million CAD | -6.74% |
| 2013 | 257.65 Million CAD | 39.37% |
| 2012 | 184.86 Million CAD | 1991.03% |
| 2011 | 8.84 Million CAD | -52.04% |
| 2010 | 18.43 Million CAD | 160.82% |
| 2009 | 7.06 Million CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| 2004 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 53.94 Million CAD | -5.61% |
| 2024 Q2 | 47.4 Million CAD | -12.13% |
| 2023 Q1 | 112.68 Million CAD | -10.01% |
| 2023 Q2 | 110.96 Million CAD | -1.53% |
| 2023 Q4 | 57.14 Million CAD | -47.61% |
| 2023 FY | 57.14 Million CAD | -54.36% |
| 2023 Q3 | 109.07 Million CAD | -1.7% |
| 2022 Q2 | 134.23 Million CAD | 2.33% |
| 2022 Q4 | 125.21 Million CAD | -5.29% |
| 2022 FY | 125.21 Million CAD | 0.73% |
| 2022 Q1 | 131.18 Million CAD | 5.53% |
| 2022 Q3 | 132.21 Million CAD | -1.51% |
| 2021 FY | 124.3 Million CAD | 63.33% |
| 2021 Q2 | 78.48 Million CAD | 24.11% |
| 2021 Q3 | 121.86 Million CAD | 55.28% |
| 2021 Q4 | 124.3 Million CAD | 2.01% |
| 2021 Q1 | 63.23 Million CAD | -16.92% |
| 2020 Q2 | 81.81 Million CAD | 30.79% |
| 2020 Q1 | 62.55 Million CAD | 203.93% |
| 2020 Q4 | 76.1 Million CAD | -3.05% |
| 2020 FY | 76.1 Million CAD | 269.8% |
| 2020 Q3 | 78.5 Million CAD | -4.04% |
| 2019 Q4 | 20.58 Million CAD | 31.52% |
| 2019 Q2 | 15.53 Million CAD | -22.51% |
| 2019 FY | 20.58 Million CAD | 10454.36% |
| 2019 Q3 | 15.64 Million CAD | 0.73% |
| 2019 Q1 | 20.04 Million CAD | 10180.51% |
| 2018 Q2 | 75.76 Million CAD | -3.83% |
| 2018 FY | 195 Thousand CAD | 43.38% |
| 2018 Q4 | 195 Thousand CAD | -15.22% |
| 2018 Q3 | 230 Thousand CAD | -99.7% |
| 2018 Q1 | 78.78 Million CAD | 57831.62% |
| 2017 Q3 | 76.63 Million CAD | -1.43% |
| 2017 Q4 | 136 Thousand CAD | -99.82% |
| 2017 FY | 136 Thousand CAD | -99.78% |
| 2017 Q1 | 25.88 Million CAD | -58.09% |
| 2017 Q2 | 77.75 Million CAD | 200.35% |
| 2016 Q3 | 67.86 Million CAD | -13.93% |
| 2016 Q1 | 62.16 Million CAD | -71.11% |
| 2016 Q4 | 61.77 Million CAD | -8.98% |
| 2016 FY | 61.77 Million CAD | -71.29% |
| 2016 Q2 | 78.84 Million CAD | 26.85% |
| 2015 FY | 215.16 Million CAD | -10.46% |
| 2015 Q1 | 242.39 Million CAD | 0.87% |
| 2015 Q2 | 220.96 Million CAD | -8.84% |
| 2015 Q3 | 222.18 Million CAD | 0.55% |
| 2015 Q4 | 215.16 Million CAD | -3.16% |
| 2014 Q2 | 237.84 Million CAD | -9.63% |
| 2014 FY | 240.29 Million CAD | -6.74% |
| 2014 Q4 | 240.29 Million CAD | 0.44% |
| 2014 Q1 | 263.18 Million CAD | 2.15% |
| 2014 Q3 | 239.24 Million CAD | 0.59% |
| 2013 Q1 | 194.42 Million CAD | 5.17% |
| 2013 Q2 | 247.88 Million CAD | 27.5% |
| 2013 Q3 | 246.34 Million CAD | -0.62% |
| 2013 Q4 | 257.65 Million CAD | 4.59% |
| 2013 FY | 257.65 Million CAD | 39.37% |
| 2012 Q2 | 201.68 Million CAD | 1732.99% |
| 2012 FY | 184.86 Million CAD | 1991.03% |
| 2012 Q4 | 184.86 Million CAD | -4.79% |
| 2012 Q3 | 194.17 Million CAD | -3.72% |
| 2012 Q1 | 11 Million CAD | 24.45% |
| 2011 Q2 | 137.42 Million CAD | 2360.54% |
| 2011 Q4 | 8.84 Million CAD | -94.04% |
| 2011 Q3 | 148.37 Million CAD | 7.97% |
| 2011 FY | 8.84 Million CAD | -52.04% |
| 2011 Q1 | 5.58 Million CAD | -69.7% |
| 2010 Q4 | 18.43 Million CAD | 227.38% |
| 2010 Q1 | 6.59 Million CAD | -6.75% |
| 2010 Q2 | 6.11 Million CAD | -7.25% |
| 2010 Q3 | 5.63 Million CAD | -7.88% |
| 2010 FY | 18.43 Million CAD | 160.82% |
| 2009 Q2 | 8.1 Million CAD | 0.0% |
| 2009 Q3 | 7.58 Million CAD | -6.46% |
| 2009 FY | 7.06 Million CAD | 0.0% |
| 2009 Q4 | 7.06 Million CAD | -6.79% |
| 2009 Q1 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2005 Q4 | - CAD | 0.0% |
| 2005 Q2 | - CAD | 0.0% |
| 2005 Q1 | - CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| 2004 Q2 | - CAD | 0.0% |
| 2004 Q3 | - CAD | 0.0% |
| 2004 Q1 | - CAD | 0.0% |
| 2004 Q4 | - CAD | 0.0% |
| 2004 FY | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q3 | 105 Thousand CAD | 0.0% |
| 2003 Q2 | 105 Thousand CAD | 0.0% |
| 2003 Q4 | - CAD | -100.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | 1.82 Million USD | -3028.933% |
| Arem Pacific Corporation | 151.51 Thousand USD | -37618.876% |
| Assisted 4 Living, Inc. | - USD | -Infinity% |
| BioCorRx Inc. | 3.89 Million USD | -1367.16% |
| Bionik Laboratories Corp. | 2.39 Million USD | -2290.929% |
| Banyan Corp. | 2.43 Million USD | -2250.399% |
| Clearday, Inc. | 25.8 Million USD | -121.433% |
| Dental Patient Care America, Inc. | - USD | -Infinity% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | 1.93 Million USD | -2859.803% |
| First Choice Healthcare Solutions, Inc. | 1.28 Million USD | -4352.16% |
| Selectis Health, Inc. | 25.17 Million USD | -126.994% |
| Ethema Health Corporation | 20.52 Thousand USD | -278403.899% |
| HealthLynked Corp. | 450 Thousand USD | -12599.778% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | - USD | -Infinity% |
| JRSIS Health Care Corporation | 24.95 Thousand USD | -228954.108% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 54.46 Million USD | -4.92% |
| MedSmart Group Inc. | 50 Thousand USD | -114198.0% |
| North America Frac Sand, Inc. | - USD | -Infinity% |
| Nova Leap Health Corp. | 914.05 Thousand USD | -6152.243% |
| Nexteligent Holdings, Inc. | - USD | -Infinity% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 6.89 Million USD | -728.889% |
| Raffles Medical Group Ltd | 52.43 Million USD | -8.988% |
| Ryman Healthcare Limited | 1.52 Billion USD | 96.246% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 57.07 Thousand USD | -100022.637% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | 58 Thousand USD | -98432.759% |
| Veltex Corporation | - USD | -Infinity% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | - USD | -Infinity% |